Strategic collaborations and partnership among key players is expected to drive the market growth over the forecast period
Key players in the market are involved in strategic partnership and acquisition, in order to expand product access in a large area and to gain major market share. Thus, such strategic penetration of key players in wide geography is expected to create a lucrative environment for the global 3D printing for medical sector market growth.
For instance, in August 2019, Materialise NV, a Belgium-based developer of 3D printing solutions, announced a strategic investment in Engimplan, a Brazil-based manufacturer of orthopedic and cranio-maxillofacial (CMF) implants and instruments. Materialise has signed an agreement to acquire a 75% stake in Engimplan through a combined acquisition of existing and new shares via its Brazilian subsidiary Engimplan Holding Ltda.
The combination of Materialise’s expertise in 3D printed medical solutions with Engimplan’s innovative product portfolio will help to accelerate the introduction of 3D printed, personalized implants and instruments in the Brazilian market.
Key players operating in the global 3D Printing for Medical Sector market include EnvisionTEC, Inc., Arcam AB, 3D Systems, Inc., Eos GmbH Electro Optical Systems, Renishaw PLC, Stratasys Inc., Materialise NV, Organovo Holdings, Inc., and 3T RPD, Ltd.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients